WEST DEPTFORD – August 13, 2013 – Johnson Matthey (LSE: JMAT) has announced that their global Catalysis and Chiral Technologies technology business unit, JMCCT, which provides trusted expertise in heterogeneous, homogeneous, chiral and biocatalytic technologies for customers in the pharmaceutical, fine chemical and agrochemical industries, is expanding its existing specialty ligand manufacturing capability to include commercial-scale manufacturing up to 100 kilograms. The company has a diverse specialty ligands portfolio, and this expansion is largely focused on the Buchwald ligands from the Massachusetts Institute of Technology for customers throughout Europe, Asia and the United States.
“The ability to offer Buchwald ligands from research through to commercial scale creates a unique, global position in the market that complements Johnson Matthey’s wide range of catalyst technologies,” commented Daren Bryce, Commercial Manager at Johnson Matthey Catalysis and Chiral Technologies. “Through our development, scale-up and manufacturing initiatives, Johnson Matthey is committed to providing the highest quality ligands that deliver value and efficiency to our customers.”
The Buchwald ligands offered by JMCCT are a class of bulky and electron-rich dialkylbiaryl monophosphine ligands, which are used for the in situ generation of active catalysts. These ligands are used for coupling reactions in the manufacture of both pharmaceuticals and specialty chemicals and are more commonly offered at a research scale for use in the laboratory.
The expansion will also complement JMCCT initiatives to continually create a stronger global supply chain. As Bryce further noted, “Three separate expansion investments have now been made, focused on a new facility in Taloja, India last year and further expansion underway in Royston, UK.”
To learn more about the JMCCT product and service offering, please visit: http://jmcct.com/products-services
About Johnson Matthey
Johnson Matthey is a specialty chemicals company with operations in over 30 countries worldwide. Organized into five global divisions: Environmental Technologies; Process Technologies; Precious Metal Products; Fine Chemicals and New Business Development, Johnson Matthey manufactures an expansive portfolio of chemicals, catalysts, and precious metals with a focus on industry leading supply chain security. Key offerings in the portfolio include autocatalysts, heavy-duty diesel catalysts and pollution control systems, catalysts and components for fuel cells, catalysts and technologies for chemical processes, fine chemicals, chemical catalysts and active pharmaceutical ingredients and the marketing, refining and fabrication of precious metals.
To learn more, please visit www.matthey.com
About Johnson Matthey Catalysis and Chiral Technologies
Johnson Matthey Catalysis and Chiral Technologies (JMCCT), is a global catalytic technology partner offering trusted expertise in heterogeneous, homogeneous, chiral and biocatalytic technologies. Catered to customers in the pharmaceutical, fine chemical and agrochemical industries, JMCCT is dedicated to delivering high quality products that add value and meet individual customer needs from research to commercial scale. As one of the only companies able to offer a full suite of coupling technologies, with a particular focus in active coupling, JMCCT is committed to exceptional customer support complemented by an industry leading approach to supply chain security.
To learn more, please visit www.jmcct.com